The Patent Finder

Galectin Therapeutics, Inc.

Also on record
Records under this name other than the patents Galectin Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.

Showing 1 to 10 of 10 · Back to Galectin Therapeutics, Inc.

PatentTitleStatus Expires Confidence
US 8,367,638Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,722,645Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,872,909Method for enhancing specific immunotherapies in cancer treatment
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,491,708Modified pectin
Formerly held
Term ended
Term ended Feb 17, 2026 · From the USPTO record
Term endedTerm ended Feb 17, 2026From the USPTO record
US 7,893,252Selectively depolymerized galactomannan polysaccharide
Term ended
Term ended Sep 8, 2023 · From the USPTO record
Term endedTerm ended Sep 8, 2023From the USPTO record
US 7,012,068Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
Term ended
Term ended Dec 22, 2022 · From the USPTO record
Term endedTerm ended Dec 22, 2022From the USPTO record
US 6,642,205Methods and compositions for reducing side effects in chemotherapeutic treatments
Term ended
Term ended Sep 24, 2021 · From the USPTO record
Term endedTerm ended Sep 24, 2021From the USPTO record
US 6,982,255Delivery of a therapeutic agent in a formulation for reduced toxicity
Term ended
Term ended Jul 19, 2021 · From the USPTO record
Term endedTerm ended Jul 19, 2021From the USPTO record
US 6,645,946Delivery of a therapeutic agent in a formulation for reduced toxicity
Term ended
Term ended May 21, 2021 · From the USPTO record
Term endedTerm ended May 21, 2021From the USPTO record
US 6,914,055Delivery of a therapeutic agent in a formulation for reduced toxicity
Term ended
Ended no later than Mar 27, 2021 · From the USPTO record
Term endedEnded no later than Mar 27, 2021From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited